Diagnostic and treatment approaches involving transthyretin in amyloidogenic diseases

GY Park, A Jamerlan, KH Shim, SSA An - International journal of …, 2019 - mdpi.com
Transthyretin (TTR) is a thyroid hormone-binding protein which transports thyroxine from the
bloodstream to the brain. The structural stability of TTR in tetrameric form is crucial for …

Diagnosis and therapeutic approaches to transthyretin amyloidosis

Y Ando, M Ueda - Current medicinal chemistry, 2012 - ingentaconnect.com
Hereditary amyloidogenic transthyretin (TTR)(ATTR) amyloidosis is an autosomal dominant
form of fatal hereditary amyloidosis. Owing to progress in biochemical and molecular genetic …

Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis

A Carroll, PJ Dyck, M de Carvalho… - Journal of Neurology …, 2022 - jnnp.bmj.com
Hereditary transthyretin amyloidosis (ATTRv) is a severe, adult-onset autosomal dominant
inherited systemic disease predominantly affecting the peripheral and autonomic nervous …

[HTML][HTML] Modulation of the mechanisms driving transthyretin amyloidosis

F Bezerra, MJ Saraiva, MR Almeida - Frontiers in Molecular …, 2020 - frontiersin.org
Transthyretin (TTR) amyloidoses are systemic diseases associated with TTR aggregation
and extracellular deposition in tissues as amyloid. The most frequent and severe forms of …

Ultrastructure in transthyretin amyloidosis: from pathophysiology to therapeutic insights

H Koike, M Katsuno - Biomedicines, 2019 - mdpi.com
Transthyretin (TTR) amyloidosis is caused by systemic deposition of wild-type or variant
amyloidogenic TTR (ATTRwt and ATTRv, respectively). ATTRwt amyloidosis has …

Pathogenesis of and therapeutic strategies to ameliorate the transthyretin amyloidoses

Y Sekijima, JW Kelly, S Ikeda - Current pharmaceutical design, 2008 - ingentaconnect.com
Transthyretin (TTR) is a homotetrameric serum and cerebrospinal fluid protein that
transports both thyroxine (T4) and the retinol-retinol binding protein complex (holoRBP) …

Hereditary transthyretin amyloidosis: a comprehensive review with a focus on peripheral neuropathy

L Poli, B Labella, S Cotti Piccinelli, F Caria… - Frontiers in …, 2023 - frontiersin.org
Amyloidoses represent a group of diseases characterized by the pathological accumulation
in the extracellular area of insoluble misfolded protein material called “amyloid”. The …

An evaluation of patisiran: a viable treatment option for transthyretin-related hereditary amyloidosis

P Milani, R Mussinelli, S Perlini… - Expert Opinion on …, 2019 - Taylor & Francis
Introduction: Hereditary transthyretin-mediated amyloidosis (ATTRv; v for variant) is a rare,
progressive, fatal multi-systemic disease, autosomal dominantly inherited with …

Transthyretin amyloidosis: an under-recognized neuropathy and cardiomyopathy

NJ Galant, P Westermark, JN Higaki… - Clinical …, 2017 - portlandpress.com
Transthyretin (TTR) amyloidosis (ATTR amyloidosis) is an underdiagnosed and important
type of cardiomyopathy and/or polyneuropathy that requires increased awareness within the …

Genetic testing improves identification of transthyretin amyloid (ATTR) subtype in cardiac amyloidosis

EE Brown, YZJ Lee, MK Halushka, C Steenbergen… - Amyloid, 2017 - Taylor & Francis
Amyloidosis is a group of conditions characterized by the accumulation of amyloid deposits
in various tissues. Among these disorders, ATTR amyloidosis occurs either with or without a …